Looking for reliable medications to treat 'Astrocytoma'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications. For informed ...

This page lists all known medications that could potentially lead to 'Astrocytoma' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery. The Food and Drug Administration (FDA) has approved ...

DelveInsight's Anaplastic Astrocytoma Market Insights report includes a comprehensive understanding of current treatment practices, anaplastic astrocytoma emerging drugs, market share of individual ...

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an ...

The Food and Drug Administration accepted an Investigational New Drug application for MB-109, a novel agent that combines two mechanisms to treat recurrent glioblastoma and high-grade astrocytroma.

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Astrocytoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...

Advantages of Concurrent Biochemotherapy Modified by Decrescendo Interleukin-2, Granulocyte Colony-Stimulating Factor, and Tamoxifen for Patients With Metastatic Melanoma PURPOSE: To determine the ...

Phase I study of PD-L1 inhibition with avelumab and laser interstitial thermal therapy in patients with recurrent glioblastoma. Background: IDH mutant astrocytomas express high levels of ...